Quantcast
Channel: Leaders in Pharmaceutical Business Intelligence » cardiovascular risk
Viewing all articles
Browse latest Browse all 2

ROFECOXIB

0
0
Larry H. Bernstein, MD, FCAP, Reporter, Reposted Leaders in Pharmaceutical Intelligence DR ANTHONY MELVIN CRASTO …..FOR BLOG HOME CLICK HERE http://pharmaceuticalintelligence.com/10/29/2010/larryhbern/Rofecoxib ROFECOXIB MK-966, MK-0966, Vioxx 162011-90-7 C17-H14-O4-S 314.3596 \ Percent Composition: C 64.95%, H 4.49%, O 20.36%, S 10.20% LitRef: Selective cyclooxygenase-2 (COX-2) inhibitor. Prepn: Y. Ducharme et al., WO 9500501; eidem, US5474995 (both 1995 […]

Viewing all articles
Browse latest Browse all 2

Latest Images

Trending Articles





Latest Images